• Provide preclinical consulting services that help clients navigate the drug discovery and development pipelines to develop innovative and exceptional products. • Design and pinpoint the precise models most appropriate for Biotechnology and Pharmaceutical companies’ drug development programs in immuno-oncology and other disease states. • Support companies in the immunology and oncology domain through all the preclinical phases of drug discovery and preclinical development for both small molecules and large biologics.